Zoledronic Acid Effectively Prevents Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole: Z-FAST Study 36-Month Follow-up Results

Autor: Brufsky, Adam M., Bosserman, Linda D., Caradonna, Richard R., Haley, Barbara B., Jones, C. Michael, Moore, Halle C.F., Jin, Lixian, Warsi, Ghulam M., Ericson, Solveig G., Perez, Edith A.
Zdroj: In Clinical Breast Cancer 2009 9(2):77-85
Databáze: ScienceDirect